Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain. - Wikidata - awgldk - TriplyDB

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

http://www.wikidata.org/entity/Q37731710

about

Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study.Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress.The emerging role of PET imaging in dementia.18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.Head to head comparison of [(18)F] AV-1451 and [(18)F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia.Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.New advances in tau imaging in parkinsonism.Multimodal correlation of dynamic [18F]-AV-1451 perfusion PET and neuronal hypometabolism in [18F]-FDG PET.Flortaucipir tau PET imaging in semantic variant primary progressive aphasia.Characterization of the radiosynthesis and purification of [18F]THK-5351, a PET ligand for neurofibrillary tau.In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line.Tau Diagnostics and Clinical Studies.Preclinical Evaluation of (18)F-RO6958948, (11)C-RO6931643 and (11)C-RO6924963 as Novel Radiotracers for Imaging Aggregated Tau in AD with Positron Emission Tomography.Small-molecule PET Tracers for Imaging Proteinopathies.Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([(18)F]-AV-1451) Binding.Tau Filaments and the Development of Positron Emission Tomography Tracers.Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.PET imaging of tau protein targets: a methodology perspective.Neuroimaging in Dementia.The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases.Molecular imaging: What is right and what is an illusion?Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias.Comparison of 18F-T807 and 18F-THK5117 PET in a Mouse Model of Tau Pathology.Role of Neuroimaging as a Biomarker for Neurodegenerative Diseases.18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies.Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding.Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy.Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?The development and validation of tau PET tracers: current status and future directions In vivo quantification of neurofibrillary tangles with [F]MK-6240 Imaging Protein Misfolding in the Brain Using β-Sheet Ligands Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer's Disease: A PET (THK5351, PiB) and Resting fMRI Study The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid β Peptide Fibrils Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO [F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review

P2860

Q41454666-E6271F58-D6DB-4EEC-BD9A-24A3B06193EC Q42361526-3EAC3CCC-F128-4CB4-834D-A1A6473A1185 Q42701971-0208A2C8-95C3-4603-AB58-931CE67E6545 Q46616293-15B75244-6FB3-4809-B37D-AB69CC458D92 Q46753514-67C3CD68-B9D0-440B-B121-996ADCD6B10F Q47140361-52A56C2A-1C61-4E8C-A95E-75ABC60CE5DE Q47254408-2826D513-24A0-41EB-BF97-4C94D7FB64DA Q47329627-31EBB027-1736-4F22-9471-BD5F2A3A952C Q47659524-36FCF983-4C61-4CDF-88D0-61E3B669D1D6 Q47684719-ACED366B-0B56-4FE8-A277-46EE6AB4A633 Q47739900-A1DA67D9-E1D9-4D0B-B170-7B58C72FD0F2 Q47835964-62BA3C23-6F59-4383-B47D-CE4027B89823 Q47870437-D39B0970-87A7-4E5D-9D96-573ABA5B15E1 Q47918679-DFE8CED5-6EBC-4388-B4B8-9BB51DCA1193 Q47926474-03ABC50F-1916-4478-A6CB-F12D0AF44CFE Q49295547-4BF49872-3AF9-4490-B2F4-8153C3F7EE15 Q50042841-A99B27DF-E74C-48D9-9FDB-4BC58AB04648 Q50061690-53D157C2-55B6-4741-A571-DACC0F85C2E9 Q50350781-D7CF3598-577E-4C8D-A3FE-5FEB2557B60B Q51765788-920358E2-8C77-4675-B0D1-2294F31484EA Q51766173-9BBC983A-CC9B-476F-B853-3C0BC97EFF17 Q51800676-094D640A-DF9A-4288-A7A8-CEDA160B5B39 Q55020340-0E49A82A-1256-4ADF-8617-727023346FDB Q55031324-D9603B32-BA94-4261-8B3E-DD9F89048161 Q55254017-AFD2CE50-253E-4EA2-889A-091BCA93ABED Q55339752-DF04F1B1-920A-426F-8C53-7C3AFE460F4F Q55344088-50938F67-7723-4A6A-B217-E8230B2D3175 Q55359027-F1EBFB27-0755-4F7F-A881-C459D8AA7823 Q55416644-E5D14789-36E2-4646-BD7F-0EEF2F801914 Q55494083-D4C83CA3-9A16-4CE3-BB80-7DC7816A7FAE Q55497377-AC358EE6-423F-4E8F-BE7A-D20539B2530F Q56594907-E34A98E1-32ED-488D-B3C1-97565D010F7E Q57040143-BB0BE5DA-458D-4FF1-8338-70F76588DC6B Q57168250-6B093CC4-C6F9-422E-B75C-002D04C51133 Q57817897-7D43F41F-47AB-4C63-A24A-3DC8BC59D615 Q58740165-C8230006-2253-4B3F-91B8-C59F5EB50EF1 Q58751451-34099B60-B133-46A0-BBC7-2BABCA0E9C74 Q58794629-8D89A473-A408-4F69-8A04-E193A68A16B8

P2860

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

http://www.wikidata.org/entity/Q37731710

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

@en

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

@nl

type

label

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

@en

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

@nl

prefLabel

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

@en

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

@nl

P1433

Q37731710-18402741-AE0B-4C16-A779-056DFA91A20E

P1476

Q37731710-4561464A-BAFC-441A-8574-62F000292D6F

P2093

Q37731710-0AB3D4CC-AAC5-469A-9625-8426ACC84178

Q37731710-57A3EBD5-C9C7-492F-B945-9D6241BBBDDC

Q37731710-5CC298B4-1D13-4C43-90DD-1D7051FD6A77

Q37731710-7167C794-1DB0-4BCA-9DC0-122FD15025BC

Q37731710-9797B661-1B62-4673-A2BD-E86CB3AF2F67

Q37731710-9ABF6DE9-E505-4955-AE1D-79DD656CB10D

Q37731710-A2A13FFC-99CF-49AD-BA54-205A3BC7CD9C

Q37731710-A524FB73-68C4-4F42-8E8A-0147C0A0CAC5

Q37731710-B63361EE-C423-4F5A-9ECF-E1B427932626

Q37731710-C7E40A58-43D8-4A23-8FC4-8E7007197826

P2860

Q37731710-04B88515-9B46-4884-B4A5-97CA00250C0A

Q37731710-0984CB54-974F-4892-B3BF-87F563C323A7

Q37731710-0A034B37-DBB3-48F2-888F-D7D41FBC2F5E

Q37731710-1AAD21A5-A20D-4F8E-88B2-D854B5D64235

Q37731710-1B5E92F1-0861-4410-ADFA-E982B3211F26

Q37731710-27AD372B-4957-44DB-B890-605577A72E2A

Q37731710-2A440CEA-E561-40B7-93C5-AD0AA5B1BFAF

Q37731710-31B6DCE7-CE4F-4500-BFF1-B176F39FAE5B

Q37731710-53F2F2E4-FC46-4090-8963-BC895DB2148C

Q37731710-5AD7DD3C-6E08-4D35-8996-F96AD8689F95

P2888

Q37731710-10FAF5CF-CEF0-4868-B4A0-957AEF1D4481

P304

Q37731710-1885032F-DB5C-468D-A395-825EB78D8059

P31

Q37731710-34EBC1AC-C454-4A43-B302-54AC429C67AD

P356

Q37731710-4E1A1EE9-BB95-4F65-A1FC-0D90F8C80C78

P407

Q37731710-897DDA49-D9A8-4675-AFD8-F297846186B1

P433

Q37731710-5EF35F4B-7143-4A3B-906C-19F62784F972

P478

Q37731710-1AE36A69-C76F-414E-B3C0-D407FE5EDA9A

P50

Q37731710-2F8A8865-CDD2-4DEA-9D36-ED7EC1FE3767

Q37731710-835E88E7-9924-4B90-9397-1727D66E15A9

Q37731710-D699B502-8E0A-458E-8E6D-F0C7823D5F50

P577

Q37731710-7B162A53-16D5-4373-8EC9-D08BC92DCB45

P6179

Q37731710-08895253-24D5-4008-88C3-29738AF217F4

P698

Q37731710-13B35C17-F71E-4EA6-A517-4691663B9DB3

P932

Q37731710-3EC11019-31CE-4A35-8980-FD2F9C0B434F

P356

S13195-017-0253-Y

P1433

Alzheimers Research & Therapy

P1476

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

@en

P2093

Gassan Massarweh

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Soucy

http://www.w3.org/2001/XMLSchema#string

Joseph Therriault

http://www.w3.org/2001/XMLSchema#string

Kok Pin Ng

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Guiot

http://www.w3.org/2001/XMLSchema#string

Min Su Kang

http://www.w3.org/2001/XMLSchema#string

Monica Shin

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Okamura

http://www.w3.org/2001/XMLSchema#string

Qi Guo

http://www.w3.org/2001/XMLSchema#string

Ryuichi Harada

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of monoamine oxidase B in the brains of smokers

“Mini-mental state”

Neuropathological alterations in Alzheimer disease

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Tau imaging: early progress and future directions

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Mild cognitive impairment as a diagnostic entity

Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis.

Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

P2888

s13195-017-0253-y

P304

25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13195-017-0253-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Robert A. Comley

Pedro Rosa-Neto

Tharick A Pascoal

P577

2017-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084252361

http://www.w3.org/2001/XMLSchema#string

P698

28359327

http://www.w3.org/2001/XMLSchema#string

P932

5374697

http://www.w3.org/2001/XMLSchema#string